Johnson & Johnson is drawing fresh call interest today. The FDA approved a new TREMFYA indication for psoriatic arthritis. Short interest sits at just 0.9% of free float. That low short base makes a sharp call-driven rally more likely on positive news.
Tesla options remain active amid political crossfire. California Governor Gavin Newsom attacked Elon Musk publicly Thursday. TSLA has 26 expiry dates between now and August 21. Open interest at deep in-the-money calls dwarfs put activity at equivalent strikes. The $5 call still holds over 9,000 contracts in open interest. That skew signals traders are defending long positions rather than speculating on downside.
Okta appeared on CNBC's "Final Trades" today. Its options calendar is lean — just nine expiries through August. That thin structure can amplify moves when volume spikes into a single expiry.
Wynn Resorts also made the CNBC watchlist. June 18 expiry is its heaviest near-term date. Any macro shift on China travel demand could move the whole chain quickly.
Broad market context matters this week. Oil supply fears from a Strait of Hormuz blockade are circling macro desks. Energy stress tends to push SPY put volumes higher as hedges. Traders should watch whether that macro fear bleeds into single-name tech put flows over the next week.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
